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Endocytosis can best be described as the process whereby particles or solutes, present in 
the external environment, are taken up into eukaryotic cells within membrane bound 
transport vesicles derived by the invagination and pinching-off of pieces of plasma 
membrane (Gagescu et al. 2000). Importantly, essential small molecules are able to 
traverse the plasma membrane through the action of integral membrane protein pumps or 
channels, whereas macromolecules have to be endocytosed within transport vesicles. 
Endocytosis can be mechanistically categorised into two groups: phagocytosis and 
pinocytosis (Figure I). Phagocytosis, or cell eating, typically involves the uptake of large 
particles and is usually limited to specialised cells such as mammalian macrophages and 
Dictyostelium amoeba (Araki et al. 1996, Seastone et al. 1998). Conversely, pinocytosis, 
also known as cell drinking, occurs in all eukaryotic cell types where fluid and solutes are 
internalised by at least one of four basic pathways; macropinocytosis, clathrin-mediated 
endocytosis (CME), caveolae-mediated endocytosis and clathrin- and caveolae-
















Phagocytosis in mammalian macrophages is an active process regulated by cell surface 
receptors and signalling cascades coordinated by Rho-family GTPases. Signalling 
cascades result in the formation of cell surface extensions (pseudopods) which engulf 
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togethler with their 95 % confidence intervals and final 
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9.63 - 12.51 
6.76 14.36 
61.61 - 89.50 
14.87 30.91 











0.0005 % DMSO 
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Nonnalised PMlthr."""ctp counts before & after 5 hours of 50 nM 
treatment. F.r'l>'fhrnc"tIT,,<:: were "'~IJ~U""'-' in culture medium with a final haematocrit of 2 %. 
were counted before and after incubation with the various treatment means of a 
The mean of three "n.rtf"'''(,'\Jt,, counts ... ",·tr.''TT\~.rl before and after 
treatment exposure were ('nTnno,rpn gniilicam:e was set at a 0.05. n number of observations. 
Treatment % Statistical Two-tailed 
Before After n Outcome 
test P value 
NO 
100 ± 7.71 96.82 9.55 3%! 15 p 0.7973 
D T test 
NO 
[1 



















































Solvent control treatment Drug treatment 
Figure 2. Representative Giemsa stained malaria parasitised red blood cells after 14 hours of 50 nM 
Cytochalasin D (0.0005 % DMSO), I flM Jasplakinolide (0.1 % DMSO) and 10 flM Latrunculin A (0.1 % 
DMSO) treatment. Treatment regimens are indicated on the left followed by representative images of 
solvent control (no drug) and drug-treated parasitised erythrocyte cultures. Densely localised malaria 
pigment of solvent control treated parasites are denoted by means of white arrows while postulated 











2.2.4 The effect of actin disrupting drug treatment on haemoglobin 
levels in malaria parasites 
Malaria parasites endocytose large quantities of haemoglobin from the red blood cell 
cytoplasm. A reduction of parasite haemoglobin levels following drug treatment would be 
predictive of a block in endocytosis while an increase could signify inhibition of digestion. 
To determine the effects of actin disrupting drugs on the haemoglobin levels in the 3D7 
strain of P. Jalciparum, a parasite culture at approximately 10 % parasitemia was split into 
two and exposed to either drug or solvent control. Parasites were either incubated in 50 
nM Cytochalasin D, 1 ~M Jasplakinolide, or 10 ~M Latrunculin A for 5 or 14 hours, 
followed by Western blotting with anti-haemoglobin antiserum before comparisons were 
made between drug and control treated parasites. 
Cytochalasin D and Latrunculin A treated parasites showed significantly increased 
haemoglobin levels, represented graphically in Figure 3 A & B. By contrast Jasplakinolide 
treatment over both exposure times significantly reduced haemoglobin levels within the 
parasite (Figure 3 C). As Mefloquine is known to inhibit endocytosis and significantly 
reduce parasite haemoglobin levels (Hoppe et al. 2004), it was used as a positive control. 
Here, 156 nM of Mefloquine over both 5 and 14 hours of exposure to parasite cultures 
reduced haemoglobin levels significantly (Figure 3 D). Complete assay results are 
summarised in Table 3. 
These results suggested that the actin filament stabilising Jasplakinolide, like Mefloquine, 
may inhibit haemoglobin endocytosis. By contrast, the actin depolymerising drugs 
Cytochalasin D and Latrunculin A raised haemoglobin levels, possibly by stimulating 
endocytosis or blocking haemoglobin digestion. The apparent reduction of malaria 
pigment observed in Cytochalasin D and Latrunculin A treated Giemsa-stained parasites, 











A. 50 nM Cytochalasin D 
Control 50 nM Cytochalasin 0 
B. 10 IJM Latrunculin A 
Control 10 J.lM Latrunculin A 
c. 1 IJM Jasplakinolide 
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Control 5hr M 
Figure 3. Haemoglobin levels in malaria parasites after various actin disrupting drug exposures. Parasite 
cultures (at approximately 10 % parasitemia) were split into two and either incubated with drug or solvent 
control for 5 or 14 hours. Malaria parasites were released from their host erythrocytes by saponin treatment, 
and washed extensively to remove unrelated extra-parasitic haemoglobin. Parasite pellets were run on SDS 
10%-polyacrylamide gels, and the haemoglobin levels in the parasites were determined by Western blotting 
with anti-haemoglobin antiserum. Net intensities of individual haemoglobin bands were determined with 
Kodak I D image analysis software. Western blot representative images of haemoglobin levels accumulated 
by parasites exposed to 50 nM Cytochalasin D (A), [0 11M Latrunculin A (8), I 11M Jasplakinolide (C) and 
156 nM Mefloquine (as the experiment control) (D) are shown on the left. Summarised haemoglobin 
accumulated levels after 5 and 14 hour drug treatments are represented by means of bar graphs on the right 
of each representative western blot image. Experiments were performed in triplicate on at least 3 individual 
days. Intensity levels indicated were normalised to the control set at 100 and comparisons were made. 













5 hr 50 nM 
Y lU,.,U"la",Ul D 
14 hr 50 nM 
Lvv".alO,,,Ul D 
5 hr 10 
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14 hr 10 
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5 hr 156 nM 
14 hr 156 nM 
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51 % L 24 
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2.2.5 Haemoglobin levels in the presence of protease inhibitors (PrI) 
Total haemoglobin levels in the parasite are the result of a balance between uptake 
(endocytosis) and digestion in the digestive vacuole. To further investigate the effect 
which actin disrupting drugs have on the endocytosis of haemoglobin by the malaria 
parasite from its host cytosol, parasite cultures were treated with protease inhibitors (PrI) 
in an attempt to negate digestion and use haemoglobin levels within malaria parasites as a 
more accurate gauge of endocytosis. Mefloquine, having been shown to inhibit 
endocytosis of macromolecules in the malaria parasite P. falciparum (Hoppe et al. 2004), 
was again used as the positive control. 
Five hour 50 nM Cytochalasin D treatment had no significant effect on haemoglobin 
levels within the malaria parasite when co-administered with PrI (Figure 4 A). 
Conversely, treatment with 1 flM lasplakinolide together with PrI significantly reduced 
haemoglobin uptake levels compared to PrI-treated controls (Figure 4 B). Similarly, 
156 nM Mefloquine co-administered with PrI, significantly reduced haemoglobin uptake 
levels (Figure 4 C). Complete assay results are summarised in Table 4. 
The similarity in haemoglobin levels in PrI-treated controls and PrI + Cytochalasin D 
treated parasites suggested that Cytochalasin D does not inhibit endocytosis. In addition, it 
suggested that Cytochalasin D raised haemoglobin levels in the absence of PrI by blocking 
haemoglobin digestion, not by stimulating endocytosis. The results further suggested that 
lasplakinolide may inhibit endocytosis. 
A. 50 nM Cytochalasin D 
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Figure 4. Haemoglobin levels in protease inhibitor treated malaria parasites after various actin perturbing 
drug exposures. Parasite cultures were incubated in either drug or solvent control for 5 hours with and 
without 40 11M of protease inhibitors (PrI) ALLN and E64 . Parasites were released from their host 
erythrocytes by saponin treatment, and washed extensively to remove extra-parasitic haemoglobin. Parasite 
pellets were run on SDS-polyacrylamide gels, and the haemoglobin levels in the parasites were determined 
by Western blotting with anti-haemoglobin antiserum. The net intensities of individual haemoglobin bands 
were determined with Kodak lD image analysis software. Western blot representative images of 
haemoglobin levels accumulated by parasites exposed to 50 nM Cytochalasin D (A), I 11M Jasplakinolide 
(8) and 156 nM Mefloquine (as the experiment control) (C) with and without PrI are shown on the left. 
Summarised haemoglobin accumulated levels after various treatments are represented by bar graphs on the 
right of each representative western blot image. Experiments were performed in duplicate on at least 3 
individual days. Intensity levels indicated were normalised to the control and comparisons were made using 











levels within malaria various actin treatments with and 
without PrJ. were in on at least 3 individual levels indicated 
were normalised to the control and were made statistical tests. 
was set at a. 0.05. Error bars indicate Standard Error of the Mean. n number of observations. 
Treatment Control 
0/0 Statistical 
P value Outcome n 
test 
156 nM Mann 
100 ± 1.3 53.l±3.4 47%! 47 p 0.0001 
decrease 
Mann 




100 3.3 219.7 ± 21.7 120 % i 21 P 0.0001 increase 
D 
NO 
321 ± 36.4 318.5 ± 33.6 0.2 ! 21 0.9552 T test 
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2.2.6 The effect of actin disrupting drugs on HRP uptake by malaria 
parasites 
Supplementary investigation of the effect which actin disrupting drug treatment has on the 
uptake of macromolecules by the malaria parasite from the host cytosol, involved the 
preloading of erythrocytes with an exogenous endocytic tracer, horse radish peroxidase 
(HRP), and subsequent infection with enriched malaria parasites. Following 14 hours of 
drug and control exposure, parasites were isolated from their host red blood cells and 
intra-parasitic HRP levels detennined by an enzymatic assay. 
Cytochalasin D treatment showed no significant change in HRP levels, while 
Jasplakinolide significantly reduced HRP levels after 14 hours of treatment (Figure 5). 
Complete assay results are summarised in Table 5. 
The results are consistent with those obtained by measuring haemoglobin levels after PrI 
treatment (Figure 4), suggesting that Jasplakinolide inhibits endocytosis while 





















Control Cytochalasin 0 
Figure 5. Quantitative HRP endocytosis assay for malaria parasites. Erythrocytes were preloaded with 
HRP, infected with parasites and treated with Cytochalasin D or Jasplakinolide for 14 hours. Subsequently, 
the parasites were released from their host red blood cells by saponin treatment and washed extensively to 
remove extra-parasitic HRP. Intra-parasitic HRP levels were determined spectrophotometrically, following 
incubation with the colorimetric HRP substrate o-phenylenediarnine (OPD) and H20 2 on a 
spectrophotometer set at 450 nm. Absorbance values were normalised to the solvent controls set at 100 and 











Table 5. Quantitative HRP endocytosis assay for malaria parasites. n = number of observations. 
Treatment Control Drug 




test P value 
14hr50nM Unpaired 
NO 
100 ± 4.64 108.76 ± 8.79 8%i 3 p = 0.4276 Significant Cytocha1asin D T test 
change 
14 hr 1 11M 
100 ± 9.07 38.12 ± 4.96 62%! 3 
Unpaired 
p = 0.0008 Significant 
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5 hour Treatment Regimen Phase contrast 
Solvent control for 
Cytochalasin 0 
(0.0005 % DMSO) 
50 nM Cytochalasin 0 
Solvent control for 
Latrunculin A 
(0.1 % DMSO) 
10 IJM Latrunculin A 
Solvent control for 
Jasplakinolide 
(0.1 % DMSO) 
1 IJM Jasplakinolide 
TRITC-Hb DAPI 
Figure 6. Representative microscope images demonstrating the effect of actin perturbing drugs on the sub-
cellular localisation of haemoglobin in malaria parasites by immunofluorescence. Parasitised erythrocytes 
were drug and solvent control treated for 5 hours, before being saponin treated to release excess non-
parasitic haemoglobin, followed by subsequent fixation and attachment of released parasites onto glass 
cover slips. Parasites were permeabilised and incubated with anti-haemoglobin antiserum and fluorescent 
secondary antibodies as well as DAP1 (which stains nuclei). The panels represent from left to right: 
Treatment regimen, phase contrast image, corresponding TRITC-labelled anti-haemoglobin image followed 
by DAPT-stained nuclei images. A single erythrocyte-free parasite can be seen in each phase contrast image 
with its food vacuole (dark haemozoin crystal) denoted with a black arrow. Corresponding TRITC-labelled 
anti-haemoglobin parasite images have vesicle-like structures indicated by white arrows, with the digestive 
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ShrJasp 14hrJasp 
Figure 7. Malaria parasite digestive vacuole fluorescence intensity after drug and solvent control 
treatment. Fluorescence intensity was measured within > 60 (Table 7) randomly selected parasite digestive 
vacuoles on haemoglobin IFA slides, using Adobe Photos hop software (version 7.0). Readings were 
normalised to their respective controls set at 100 and comparisons were made using appropriate statistical 
tests. Due to heterogeneity of variances and the non-normal distribution of the data, comparisons were made 
using the Non-parametric Mann-Whitney U test for independent samples. Statistical significance was set at 




























































5hr C.O. 14hr C.O. 
Significant i Significant i 
ShrJasp 14hrJasp 
Figure 8. Malaria parasite transport vesicle numbers after drug and solvent control treatment. Average 
transport vesicle counts per parasite were compared between the various drug treatments and their respective 
solvent controls. Approximately 40 to 1 00 parasites (Table 8) were randomly selected on the haemoglobin 
IFA slides and the numbers of cytoplasmic fluorescent puncta (transport vesicles) outside the digestive 
vacuoles counted. Average transport vesicle counts were normalised to their respective solvent controls 
which were set at 100 and comparisons were made using appropriate statistical tests. Due to heterogeneity of 
variances and the non-normal distribution of the data, comparisons were made using the Non-parametric 
Mann-Whitney U test for independent samples. Statistical significance was set at (l = 0.05. Error bars 











Normalised vesicle numbers within malaria after various actin 
treatments. n number of observations. 
Treatment Control 
ll/O Statistical Two tailed 
Outcome n 
test P value 
5 hr 50 nM Mann-
D 
100 ± 19.11 244.27 ± 23.94 144 % i 66 p 0.0001 
increase 
14 hr 50 nM 
100 18.40 206.80 ± 26.77 107% i 102 Mann- p = 0.0216 D increase 
Mann-
100 ± 13.44 280.85 ± 24.03 181 i 71 P < 0.0001 increase 
100± 19.67 277.08 ± 32.94 177 % i 60 Mann- p < 0.0001 increase 
14 hr 156 nM Mann- No 
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Transmission electron micrograph 
Figure 9. Transmission electron micrograph of a cross section of Cytochalasin D (CD) and JasplakinoJide 
(Jasp) treated trophozoite stage malaria parasites together with their respective controls. Labelled structures 
are the infected erythrocyte (REC), parasite (PAR), parasite nucleus (NU), digestive vacuole (VAC), and 













Control Cytochalasin D Jasplakinolide 
Figure 10. Transport vesicle numbers per malaria parasite after 5 hour actin disrupting drug exposure as 
observed by electron microscopy. Comparisons were made using the non-parametric Mann-Whitney U test 
for independent samples. Statistical significance was set at a = 0.05 . Error bars indicate standard error of the 
mean. 
Table 8. Transport vesicle numbers per malaria parasite after 5 hours of actin disrupting drug exposure as 
observed by electron microscopy. Comparisons were made using appropriate statistical tests . Statistical 
significance was set at (l = 0.05 . n = number of observations. 
0/0 Statistical Two tailed 
Treatment Control Drug n Outcome 
Change test P value 
5 hr 50 nM Mann Significant 
1.56 ± 0.11 2.74 ± 0.24 75 % i 103 p=O.OOOI 
Cytochalasin D Whitney increase 
5 hr I flM Mann Significant 
1.53±0.12 2.28 ± 0.15 50 % i 131 P = 0.0004 











'r"rl~n"rt vesicle size within malaria after 5 hours of actin exposure as 
observed electron To avoid all measurements were taken across the axis 
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310 ± 16 634 ± 35 105 % i 50 
D 
5hrt 
350 25 408 35 17% i 50 
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exposure as observed electron tn"!"""",,,,,, 
Statistical Two tailed 
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after 5 hours of actin 
all measurements were taken 
across the shortest distance between the outer membrane of the vesicle and the membrane. 
were made statistical tests. Statistical was set at a 0.05. n 
number of observations. 
Control % Statistical Two tailed 
Treatment n Outcome 
test P value 
No 
hr 50 nM 
370 ± 55 15 49 ]5 % ~ 50 P == OA528 
D T 
5hrl Mann 











2.2.9 The effect of actin disrupting drugs on the localisation of actin in 
P. Jalciparum infected erythrocytes as assessed by 
immunofluorescence assay (IFA) 
Having established actin disrupting drug effects on the localisation of parasite 
haemoglobin, IF A, using anti-actin antiserum and fluorescent secondary antibodies, was 
performed to investigate the effects these drugs have on parasite actin localisation. 
Control parasite actin appeared to be dispersed homogenously throughout the cytoplasm 
(Figure 11). Similar results were observed in parasites treated with Cytochalasin D. 
Contrastingly, Jasplakinolide treated parasites had a clearly distinguishable actin stain 
located all along the periphery of the majority of parasites. Treatment of T gondii with the 
filament-stabilising drug Jasplakinolide has been shown to increase actin polymerisation 
(Schmitz et al. 2005). It is thus likely, that Jasplakinolide, by inducing and stabilising 
actin filaments within the malaria parasite, creates a cortical actin meshwork seen in 
Figure 11. 
Treatment regimen 
0.0005 % DMSO 
(Cytochalasin 0 
solvent control) 
50 nM Cytochalasin 0 
0.1 % DMSO 
(Jasplakinolide 
solvent control) 
1 IJM Jasplakinolide 
Phase Anti-actin DAPI 
. 
. , I I 
Figure 11. Microscope images of the effect of actin perturbing drugs on the sub-cellular localisation of 
actin in malaria parasites by immunofluorescence. Parasitised erythrocytes were drug and solvent control 
treated before being saponin treated to release the parasite with subsequent fixation onto glass cover slips. 
Parasites were permeabilised before incubation with anti-actin antiserum and fluorescent secondary 
antibodies as well as DAPI. The panels represent from left to right: Treatment regimen, phase contrast 
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trafficking from early to late endosomes (Clague 1998). Notably, Wortmann in caused 
significant down regulation of cell-surface transferrin receptors resulting from increased 
intemalisation and decreased recycling rates (Spiro et al. 1996). Interestingly, in vitro 
studies have shown Wortmannin to inhibit constitutive endocytosis ofHRP and transferrin 
as well as endosome fusion (Li et al. 1995). In agreement with this, Wortmannin and 
L Y294002 were found to inhibit fluid-phase endocytosis but had little or no effect on 
clathrin-dependent intemalisation pathways (Araki et al. 1996). Perhaps these seemingly 
contradictory findings regarding the role of Wortmannin may be due to it not only 
inhibiting PI (3) kinase, but additionally other enzymes including PI (4) kinase (Richards 
et al. 2004). Furthermore, various studies using Wortmannin made use of different cell 
types and concentrations. 
PI (3) kinases are known as regulators of phagocytosis and are essential players in 
phagosome formation and maturation (Gillooly et al. 2001) (Table 1). Class I PI (3) kinase 
products, PI (3, 4) P2 and PI (3, 4, 5) P3, are required for phagocytosis of large particles 
(>3 ).lm) by means of phagosome formation. Wortmannin, which inhibits endosome-
endosome fusion (Li et al. 1995) and interferes with phagosome closure (Araki et al. 
1996), suggests that PI (3) kinase may playa role during membrane formation of 
pseudopods and phagosomes as these membrane formations are postulated to be brought 
about by electron lucent vesicle fusion processes (Lennartz 1999). Class III PI (3) kinase, 
responsible for producing phosphoinositide (3) phosphate (PI (3) P), is located within 
phagosome membranes, and is required for phagosome maturation (Gillooly et al. 2001). 
Interestingly, PI (3) kinase does not appear to be essential for phagocytosis in 
Dictyostelium, yet is required for macropinocytosis (Cardelli 2001). Contrastingly, PI (3) 
kinase may playa role during phagocytosis in mammalian cells, however, this may be by 
means of another scenario involving the actin cytoskeleton (Lennartz 1999). Class I PI (3) 
kinase products may, additionally to phagocytosis, regulate actin polymerisation by 
binding either profilin or gelsolin. These actin binding proteins bind actin monomers and 
sever actin filaments, respectively, reSUlting in actin filament depolymerisation and 































11. values for each togeth1er with their 95 % confidence intervals and final 
and solvent concentrations used 
Final Solvent 
Interval concentration used concentration 
LY294002 48.99 41.06 58.45 lO 0.01 %DMSO 
Wortmannin 54.91 43.73 68.94 lO 0.1 DMSO 
21.44 nM 14.87 - 30.91 156nM 0.006 % MeOH 
Methanol 1.01 % 0.659 1.684 0.006 % 0.006 % 
































0.1 % DMSO 
(solvent control) 
& 
10 IJM Wortmannin 
0.01 % DMSO 
(solvent control) 
& 
10 IJM L Y294002 
Solvent control treatment Drug treatment 
Figure 12. Giemsa stained parasitised red blood cells after various 5 hour phosphatidylinositol (3) kinase 
(PI (3) kinase) inhibiting drug treatments. Treatment regimens of 10 ~M Wortmannin (0.1 % DMSO) and 
10 ~M LY294002 (0.01 % DMSO) are shown on the left followed by representative solvent control and 
drug treated malaria parasitised erythrocyte images. Densely localised malaria pigment of solvent control 
treated parasites are denoted by means of white arrows while postulated haemoglobin transport vesicles of 











3.2.3 The effect of PI (3) kinase inhibiting drug treatment on 
haemoglobin levels in malaria parasites 
Malaria parasites endocytose large quantities of haemoglobin from their host erythrocyte 
cytoplasm. A reduction of parasite haemoglobin levels following drug treatment would be 
predictive of a block in endocytosis while an increase could signify inhibition of digestion. 
To determine the effects of PI (3) kinase inhibiting drugs on the haemoglobin levels in 
P falciparum, parasites were incubated in 10 J!M Wortmannin and 10 J!M L Y294002 for 5 
and 14 hours, followed by Western blotting with anti-haemoglobin antiserum. 
Wortmannin and LY294002 treated parasites showed significantly increased haemoglobin 
levels, represented graphically in Figure 13 A & B. Mefloquine was used as a positive 
control, and over both 5 and 14 hours of exposure, significantly reduced haemoglobin 
levels (Figure 13 D). Complete assay results are summarised in Table 12. 
The PI (3) K inhibiting drugs, which raised parasite haemoglobin levels, may, similarly to 
Cytochalasin D, accomplish this by either stimulating endocytosis or blocking 
haemoglobin digestion. The apparent reduction of malaria pigment observed in 
Wortmannin and LY294002 treated Giemsa-stained parasites, together with the 
significantly raised haemoglobin levels, however, suggested a block in digestion. 
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Figure 13. Haemoglobin accumulation levels in malaria parasites after various PI (3) kinase inhibiting 
drug exposures. Parasite cultures were incubated in either drug or solvent control for 5 and 14 hours . 
Malaria parasites were released from their host erythrocytes by saponin treatment, and washed extensively 
to remove unrelated extra-parasitic haemoglobin. Parasite pellets were run on SDS-polyacrylamide gels, and 
the haemoglobin levels in the parasites were determined by Western blotting with anti-haemoglobin 
antiserum. Net intensities of individual haemoglobin bands were determined with Kodak ID image analysis 
software. Western blot representative images of haemoglobin levels accumulated by parasites exposed to 
10 /lM Wortrnannin (A), 10 /lM LY294002 (8) and 156 nM Mefloquine (as the experiment control) (C) are 
shown on the left. Summarised haemoglobin accumulated levels after 5 and 14 hour drug treatments are 
represented by means of bar graphs on the right of each representative western blot image. Experiments 
were performed in triplicate on at least 3 individual days. Intensity levels indicated were normalised to the 
control set at 100 and comparisons were made. Significance was set at a = 0.05. Error bars indicate Standard 











IntJra-t)anlsltlc h,aenlog:tobllIl levels after various 
number of observations. 
Treatment Control 
5 hr 10 
LY294002 
14 hr 10 
LY294002 
5 hr 10 
W ortrnannin 
14 hr 10 
W ortrnannin 
5 hr 156 nM 
14 hr 156 nM 
100 ± 9.60 228.55 33.52 
100 ± 5.39 144.55 14.62 
100 ± 4.96 160.23 ± 18.71 
100 ± 3.43 155.05 ± 7.70 
100 ± 1.24 52.68 ± 3.45 




129 % j 21 
45 % j 15 
60%j 15 
55% j 27 
47 %! 47 
51 %! 24 
treatments. n 
Statistical Two tailed 
Outcome 




























3.2.4 Haemoglobin levels in the presence of protease inhibitors 
As stated previously, haemoglobin levels within malaria parasites reflect a balance 
between endocytosis and digestion within the digestive vacuole. Thus, similar to the actin 
inhibiting drug assay, parasite cultures were treated with PrI in an attempt to negate 
digestion and use intra-parasitic haemoglobin levels as a more accurate measure of 
endocytosis. Mefloquine was again used as the positive control. 
Five hour 10 IlM Wortmannin and 10 IlM LY294002 treatments significantly reduced 
haemoglobin levels within the malaria parasite when co-administered with PrI, compared 
to PrI-treated controls (Figure 14 A & B). Similarly, treatment with 156 nM Mefloquine 
co-administered with PrI significantly reduced haemoglobin levels (Figure 14 C). 
Complete assay results are summarised in Table 13. 
The significant reduction in haemoglobin levels in PrI-treated controls and PrI + PI (3) 
kinase inhibiting drug treated parasites suggested that Wortmannin and LY294002 
inhibited endocytosis. In addition, it suggested that Wortmannin and L Y294002 raised 
haemoglobin levels in the absence of PrI by blocking haemoglobin digestion, not by 
stimulating endocytosis. The results further confirm that Mefloquine inhibited endocytosis 
as previously reported (Hoppe et al. 2004). 
A. 10 IJM L Y294002 









































Control Wort Control + PI Wort + PI 
c. 156 nM Mefloquine 
Control MQ Control + Prl MQ + Prl 
Figure 14. Haemoglobin levels in protease inhibitor treated malaria parasites after various PI (3) kinase 
inhibiting drug exposures. Parasite cultures were incubated in either drug or solvent control for 5 hours with 
and without 40 11M of protease inhibitors (Pr!) ALLN and E64. Parasites were released from their host 
erythrocytes by saponin treatment, and washed extensively to remove extra-parasitic haemoglobin. Parasite 
pellets were run on SDS-polyacrylamide gels, and the haemoglobin levels in the parasites were determined 
by Western blotting with anti-haemoglobin antiserum. The net intensities of individual haemoglobin bands 
were determined with Kodak lD image analysis software. Western blot representative images of 
haemoglobin levels accumulated by parasites exposed to 10 11M Wortrnannin (A), 10 11M LY294002 (B) and 
156 nM Mefloquine (as the experiment control) (C) with and without Pr! are shown on the left. Summarised 
haemoglobin accumulated levels after various treatments are represented by bar graphs on the right of each 
representative western blot image. Experiments were performed in duplicate on at least 3 individual days. 
Intensity levels indicated were normalised to the control and comparisons were made using appropriate 











levels within malaria after various PI kinase 
treatments with and without PrI. were in on at least 3 individual 
levels indicated were normalised to the control and were made 
statistical tests. was set at 0. 0.05. n = number of observations. 
Statistical 
Treatment Control % n P value Outcome 
test 
156nM Mann 
100 ± 1.2 1 ± 3.4 47 ~ 47 P < 0.0001 decrease 
Mann 
232 144.4 ± 12.6 38 47 P < 0.0001 +40 PrI decrease 
10 Mann 
100 4.7 219.3 119 % t 25 p < 0.0001 
LY294002 Increase 
LY294002 
736± 84.6 420.4 49.4 43 % ~ 25 P = 0.0023 
40 PrI T test decrease 
10 Mann 
100 ± 4.0 447.7 35.9 348 % 1 17 P < 0.0001 
Wortmannin increase 
Wortmannin Mann 
S16±S5.0 367.8 45.9 29 % ~ 19 p=0.0410 










3.2.5 The effect of PI (3) kinase inhibiting drugs on HRP uptake by 
malaria parasites 
Supplementary investigation of the effect which PI (3) kinase inhibiting drug treatment 
has on the uptake of macromolecules by the malaria parasite from the host cytosol, 
involved the preloading of erythrocytes with the exogenous endocytic tracer HRP, and 
subsequent infection with enriched malaria parasites. Following 14 hours of drug and 
control exposure, parasites were isolated from their host red blood cells and intra-parasitic 
HRP levels determined by an enzymatic assay. 
Both LY294002 and Wortmannin significantly reduced intra-parasitic HRP levels after 14 
hours of treatment (Figure 15). Complete assay results are summarised in Table 14. 
In agreement with the results obtained by measunng haemoglobin levels after PrI 
treatment (Figure 15), these results confirmed Wortmannin and L Y294002 to inhibit 

























Figure 15. Quantitative HRP endocytosis assay for malaria parasites. Erythrocytes were preloaded with 
HRP; infected with parasites; and treated with LY294002 or Wortmannin for 14 hours. Subsequently, the 
parasites were released from their host red blood cells by saponin treatment and washed extensively to 
remove extra-parasitic HRP. Intra-parasitic horse radish peroxidase absorbance levels were determined 
photometrically, following incubation with the HRP substrate o-phenylenediamine (OPD), and H20 2 on a 
spectrophotometer set at 450 nm. Absorbance values were normalised to the solvent controls set at 100 and 











Table 14. Quantitative HRP endocytosis assay for malaria parasites. n = number of observations. 
0/0 Statistical Two tailed 
Treatment Control Drug n Outcome 
Change test P value 
14 hr 1O!1M 
100±3.12 64.35 ± 8.15 36% ~ 3 
Unpaired 
p = 0.0191 
Significant 
LY294002 T test decrease 
14 hr 1O!1M 
100 ± 5.71 31.73 ± 1.97 68% ~ 3 
Unpaired 
p = 0.0002 
Significant 

































Treatment Regimen Phase-contrast TRITC-Hb 
Solvent control for 
Wortmannin 
(0.1 % DMSO) 
1 0 ~M Wortmannin 
Solvent control for 
LY294002 
(0 .01 % DMSO) 
1 0 ~M L Y294002 
DAPI 
Figure 16. Microscope images demonstrating the effect of PI (3) kinase inhibiting drugs on the sub-
cellular localisation of haemoglobin in malaria parasites by immunofluorescence. Parasitised erythrocytes 
were drug and solvent control treated, before being saponin treated to release excess non-parasitic 
haemoglobin, followed by subsequent fixation and attachment of released parasites onto glass cover slips. 
Parasites were permeabilised and incubated with anti-haemoglobin antiserum and fluorescent secondary 
antibodies as well as DAPI (which stains nuclei). The panels represent from left to right: Treatment regimen, 
phase contrast image, corresponding TRITC-Iabelled anti-haemoglobin image followed by DAPI-stained 
nuclei images. A single erythrocyte-free parasite can be seen in each phase contrast image with its food 
vacuole (dark haemozoin crystal) denoted with a black arrow. Corresponding TRITC-Iabelled anti-
haemoglobin parasite images have vesicle-like structures indicated by white arrows, with the digestive 
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Control Mefloquine 5hrWort 14hr Wort 
Figure 17. Malaria parasite digestive vacuole fluorescence intensity after drug and solvent control 
treatment. Fluorescence intensity was measured within 2: 60 (Table 14) randomly selected parasite digestive 
vacuoles on haemoglobin IFA slides, using Adobe Photoshop software (version 7.0). Readings were 
normalised to their respective controls set at 100 and comparisons were made using appropriate statistical 
tests. Due to heterogeneity of variances and the non-normal distribution of the data, comparisons were made 
using the Non-parametric Mann-Whitney U test for independent samples. Statistical significance was set at 
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Mefloquine 5hr LY 14hr LY 
Significant i 
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Mefloquine 5hr Wort 14hr Wort 
Figure 18. Malaria parasite transport vesicle numbers after drug and solvent control treatment. Average 
transport vesicle counts per parasite were compared between the various drug treatments and their respective 
solvent controls. Between 40 and 60 parasites (Table 15) were randomly selected on the haemoglobin IF A 
slides and the numbers of cytoplasmic fluorescent puncta (transport vesicles) outside the digestive vacuoles 
counted. Average transport vesicle counts were normalised to their respective solvent controls which were 
set at 100 and comparisons were made using appropriate statistical tests. Due to heterogeneity of variances 
and the non-normal distribution of the data, comparisons were made using the Non-parametric Mann-
Whitney U test for independent samples. Statistical significance was set at a = 0.05 . Error bars indicate 











vacuole fluorescence levels within malaria after various 
PI (3) kinase treatments. n = number of observations. 
Treatment Control 
0/0 Statistical Two tailed 
Outcome n 
test P value 
5 hr 10 11M 100 ± 5.974 61.126±4.641 39 %! 107 
Mann-
p < 0.0001 
LY294002 decrease 
14 hr 10 
100 ± 2.841 51.962 ± 2.789 48 %! 60 
Mann-
p < 0.0001 
LY294002 decrease 
5 hr 10 
100 ± 3.938 68.956 ± 3.836 31 %! 130 
Mann-
p < 0.0001 
Wortmannin decrease 
14 hr 10 
100 ± 4.328 69.548 ± 3.277 30% ! 60 
Mann-
p < 0.0001 
Wortmannin decrease 
14 hr 156 nM 
100 ± 4.677 65.563 ± 3.748 34% ! 60 
Mann-
p < 0.0001 
decrease 
1 vesicle numbers within malaria after various PI kinase 
treatments. n = number of observations. 
Treatment Control 
''10 Statistical Two tailed Outcome n 
test P value 
5 hr 10 
100±18.31 199.19 ± 18.43 99 % i 60 P = 0.0002 
LY294002 T test increase 
14 hr 10 
100 ± 24.69 280 ± 43.70 180 % i 40 Mann- p=0.0012 
LY294002 increase 
5 hr 10 
100 ± 13.97 459.52 ± 42.99 360 % i 58 Mann- p < 0.0001 
Wortmannin increase 
14 hr 10 11M 
100 ± 23.80 377.78 ± 47.87 278%i 40 
Mann-
p < 0.0001 
W ortmaJmin increase 
14 hr 156 nM Mann-
No 
Mefloquine 
100 ± 19.46 70.97 ± 11.73 29 %! 40 
Whitney 
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Transmission electron micrograph 
Figure 19. Transmission electron micrograph of a cross section of 1 0 ~M Wortmann in and solvent control 
treated trophozoite stage malaria parasites. Labelled structures are the infected erythrocyte (RBC), parasite 
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Figure 20. Transport vesicle numbers per malaria parasite after 5 hours of 10 )lM Wortmannin exposure 
as observed by electron microscopy. Comparisons were made using the non-parametric MalU1-Whitney U 
test for independent samples. Statistical significance was set at a = 0.05. Error bars indicate standard error of 
the mean. 
Table 17. Transport vesicle numbers per malaria parasite after 5 hours of 10 )lM Wortmann in exposure as 
observed by electron microscopy. Comparisons were made using appropriate statistical tests. Statistical 
significance was set at a = 0.05. n = number of observations. 
Sta tistical Two tailed 
Treatment Control Drug % Change n Outcome 
test P value 
5 hr 10 )lM Mann Significant 
1.58 ± 0.12 3.83 ± 0.23 142 % i 112 P < 0.0001 











1 vesicle size within malaria after 5 hours of Wortmannin treatment as 
observed 
of each 
electron To avoid all measurements were taken across the 
statistical tests. Statistical 
aXIs 
vesicle. '-''-''''',,"UL were made 
was set at a = 0.05. n = number of observations. 
Control Statistical Two tailed 
Treatment 0/0 n Outcome 
test P value 
5 hr 10 !1M Mann 
322 ± 33 543 ± 26 69 % 1 50 P < 0.0001 
Wortmann in increase 
vesicle distance from the of malaria after 5 hours of 
Wortmannin treatment as observed electron llli'CroSC()PV To avoid all measurements were taken 
across the shortest distance between the outer membrane of the vesicle and the pa,a;),,,,; membrane. 
'lJ<lll;)'JU" were made 
Treatment 
5 hr 10 
Wortmannin 
370±48 344±53 
statistical tests. Statistical "'.!:,llllll"''''','-' was set at a = 0.05. 
Statistical Two tailed 
% '-'I ....... t::'" n Outcome 































0.1 % DMSO 
(Wortmannin 
solvent control) 
1 0 ~M Wortmannin 
0.01 % DMSO 
(LY294002 
solvent control) 
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Actin stain DAPI 
· tt ~ 
Figure 21. Microscope images showing the effect of PI (3) kinase inhibiting drugs on the sub-cellular 
localisation of actin by immunofluorescence. Parasitised erythrocytes w re drug and solvent control treated 
before being saponin treated to release the parasite with subsequent fixation onto glass cover slips. Parasites 
were penneabilised before incubation with anti-actin antiserum and fluorescent secondary antibodies as well 
as DAPI. The panels represent from left to right: Treatment regimen, phase contrast image, TRlTC-labelled 
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Final 
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50nM 0.0005 % DMSO 
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rinsed with water and air dried before viewing under a Leitz microscope fitted with an oil 
immersion objective. The number of parasitised RBC's divided by the total number of 
erythrocytes, both parasitised and non-parasitised, yielded the parasitemia. 
5.4 Parasite synchronisation 
Parasite cultures were routinely synchronised during ring phase of development using the 
D-sorbitol method described by Lambros & Vanderberg (1979). Suspensions were 
centrifuged at 750 rcf (relative centrifugation force) for 3 minutes with the resulting pellet, 
comprised of parasitised and non-parasitised erythrocytes, incubated in 5 volumes of 5 % 
D-sorbitol (Sigma) for 10 minutes at 37°C. The newly sorbitol treated parasite pellets 
were re-suspended in CM, causing preferential lysis of erythrocytes infected with 
trophozoite stage parasites and resulting in a predominantly ring phase infected culture 
(Figure 22 (Panel A)). Parasite cultures were predominantly in the trophozoite stage of 
development 24 hours after synchronisation as seen in Figure 22 (Panel B). 
Panel A Panel B 
Figure 22. Giemsa stained ring infected parasite culture after synchronisation using 5 % sorbitol (A). A 
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Panel A Panel B 
Figure 24. Microscope images of Giemsa stained trophozoite infected erythrocytes. Panel A represents a 
non-enriched trophozoite culture whilst Panel B represents an enriched trophozoite infected erythrocyte 
culture. 
5.7 Trophozoite isolation from host erythrocytes by saponin 
lysis 
Mid to late trophozoite stage parasites were isolated fonn their host erythrocytes using 
saponin lysis. Approximately 1 mL of parasite culture (roughly 10 % parasitemia) having 
a haematocrit of 2 % (i.e. about 20 J..lL of pRBC pellet) was centrifuged at 700 rcf for 3 
minutes before aspirating off the supernatant leaving behind the pellet of parasitised 
erythrocytes. Parasitised red blood cells collected into microcentrifuge tubes were re-
suspended into 500 J..lL of 0.1 % (w/v) saponin (Sigma) in PBS. Thereafter the parasite 
pellet was centrifuged on a microfuge at 5000 rpm for 3 minutes. The parasite pellet was 
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